Molecular and clinical profiling View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2010-2014

FUNDING AMOUNT

4401630 USD

ABSTRACT

If we will provide a better understanding of underlying mechanisms of myelomagenesis, then we will be able to reach are goals to (1) define high-risk precursor disease patinets, and to (2) delay and prevent development of multiple myeloma. For example, in 2010, we opened a treatment study for smoldering, using a novel treatment approach modality (a monoclonal antibody which targets natural killer cells, which in turn will cause anti-myeloma effect). In 2011, we have developed the second generation of treatment studies based on our generated data from the molecular profiling studies we are doing in parallel. If we will be able to goals to delay/prevent myeloma, it will have a major impact on the clinical management and outcome for these patients in the future. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8938074

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "4401630"
    }, 
    "description": "If we will provide a better understanding of underlying mechanisms of myelomagenesis, then we will be able to reach are goals to (1) define high-risk precursor disease patinets, and to (2) delay and prevent development of multiple myeloma. For example, in 2010, we opened a treatment study for smoldering, using a novel treatment approach modality (a monoclonal antibody which targets natural killer cells, which in turn will cause anti-myeloma effect). In 2011, we have developed the second generation of treatment studies based on our generated data from the molecular profiling studies we are doing in parallel. If we will be able to goals to delay/prevent myeloma, it will have a major impact on the clinical management and outcome for these patients in the future.", 
    "endDate": "2014-01-01T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.48336.3a", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2724234", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2724234"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "ZIABC011352"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "data", 
      "clinical profiling", 
      "anti-myeloma effect", 
      "parallel", 
      "outcome", 
      "example", 
      "underlying mechanisms", 
      "myelomagenesis", 
      "novel treatment approach modality", 
      "multiple myeloma", 
      "high-risk precursor disease patinets", 
      "delay", 
      "prevent myeloma", 
      "goal", 
      "future", 
      "second generation", 
      "monoclonal antibodies", 
      "Molecular", 
      "development", 
      "treatment studies", 
      "better understanding", 
      "clinical management", 
      "turn", 
      "patients", 
      "major impact", 
      "natural killer cells", 
      "molecular profiling studies"
    ], 
    "name": "Molecular and clinical profiling", 
    "recipient": [
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/None", 
          "name": "BASIC SCIENCES", 
          "type": "Organization"
        }, 
        "familyName": "LANDGREN", 
        "givenName": "OLA", 
        "id": "sg:person.0651746766.54", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0651746766.54", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2724234"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_22.xml.gz", 
    "startDate": "2010-01-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8938074"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2724234'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2724234'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2724234'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2724234'


 

This table displays all metadata directly associated to this object as RDF triples.

70 TRIPLES      19 PREDICATES      48 URIs      41 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2724234 schema:about anzsrc-for:2211
2 schema:amount Nce3617275e9d414f8bef551bb7729f62
3 schema:description If we will provide a better understanding of underlying mechanisms of myelomagenesis, then we will be able to reach are goals to (1) define high-risk precursor disease patinets, and to (2) delay and prevent development of multiple myeloma. For example, in 2010, we opened a treatment study for smoldering, using a novel treatment approach modality (a monoclonal antibody which targets natural killer cells, which in turn will cause anti-myeloma effect). In 2011, we have developed the second generation of treatment studies based on our generated data from the molecular profiling studies we are doing in parallel. If we will be able to goals to delay/prevent myeloma, it will have a major impact on the clinical management and outcome for these patients in the future.
4 schema:endDate 2014-01-01T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
6 schema:identifier N10b28e96bbe94b9483c572b7542ba7be
7 Na112a15e6103433a926cb0069947628d
8 schema:inLanguage en
9 schema:keywords Molecular
10 anti-myeloma effect
11 better understanding
12 clinical management
13 clinical profiling
14 data
15 delay
16 development
17 example
18 future
19 goal
20 high-risk precursor disease patinets
21 major impact
22 molecular profiling studies
23 monoclonal antibodies
24 multiple myeloma
25 myelomagenesis
26 natural killer cells
27 novel treatment approach modality
28 outcome
29 parallel
30 patients
31 prevent myeloma
32 second generation
33 treatment studies
34 turn
35 underlying mechanisms
36 schema:name Molecular and clinical profiling
37 schema:recipient N0b1e2afc08144402a77e02655540d6a0
38 sg:person.0651746766.54
39 schema:sameAs https://app.dimensions.ai/details/grant/grant.2724234
40 schema:sdDatePublished 2019-03-07T12:09
41 schema:sdLicense https://scigraph.springernature.com/explorer/license/
42 schema:sdPublisher N78358df487df4c8ab6b94c94a432a6d4
43 schema:startDate 2010-01-01T00:00:00Z
44 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8938074
45 sgo:license sg:explorer/license/
46 sgo:sdDataset grants
47 rdf:type schema:MonetaryGrant
48 N0b1e2afc08144402a77e02655540d6a0 schema:member sg:person.0651746766.54
49 schema:roleName PI
50 rdf:type schema:Role
51 N10b28e96bbe94b9483c572b7542ba7be schema:name nih_id
52 schema:value ZIABC011352
53 rdf:type schema:PropertyValue
54 N78358df487df4c8ab6b94c94a432a6d4 schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 Na112a15e6103433a926cb0069947628d schema:name dimensions_id
57 schema:value 2724234
58 rdf:type schema:PropertyValue
59 Nce3617275e9d414f8bef551bb7729f62 schema:currency USD
60 schema:value 4401630
61 rdf:type schema:MonetaryAmount
62 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
63 rdf:type schema:DefinedTerm
64 sg:person.0651746766.54 schema:affiliation https://www.grid.ac/institutes/None
65 schema:familyName LANDGREN
66 schema:givenName OLA
67 rdf:type schema:Person
68 https://www.grid.ac/institutes/None schema:name BASIC SCIENCES
69 rdf:type schema:Organization
70 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
 




Preview window. Press ESC to close (or click here)


...